AUC Score :
Short-Term Revised1 :
Dominant Strategy : Sell
Time series to forecast n:
Methodology : Statistical Inference (ML)
Hypothesis Testing : Wilcoxon Rank-Sum Test
Surveillance : Major exchange and OTC
1The accuracy of the model is being monitored on a regular basis.(15-minute period)
2Time series is updated based on short-term trends.
Summary
Tango Therapeutics Inc. prediction model is evaluated with Statistical Inference (ML) and Wilcoxon Rank-Sum Test1,2,3,4 and it is concluded that the TNGX stock is predictable in the short/long term. Statistical inference is a process of drawing conclusions about a population based on data from a sample of that population. In machine learning (ML), statistical inference is used to make predictions about new data based on data that has already been seen.5 According to price forecasts for 4 Weeks period, the dominant strategy among neural network is: Sell
Key Points
- Statistical Inference (ML) for TNGX stock price prediction process.
- Wilcoxon Rank-Sum Test
- Dominated Move
- Technical Analysis with Algorithmic Trading
- Prediction Modeling
TNGX Stock Price Forecast
We consider Tango Therapeutics Inc. Decision Process with Statistical Inference (ML) where A is the set of discrete actions of TNGX stock holders, F is the set of discrete states, P : S × F × S → R is the transition probability distribution, R : S × F → R is the reaction function, and γ ∈ [0, 1] is a move factor for expectation.1,2,3,4
Sample Set: Neural Network
Stock/Index: TNGX Tango Therapeutics Inc.
Time series to forecast: 4 Weeks
According to price forecasts, the dominant strategy among neural network is: Sell
n:Time series to forecast
p:Price signals of TNGX stock
j:Nash equilibria (Neural Network)
k:Dominated move of TNGX stock holders
a:Best response for TNGX target price
Statistical inference is a process of drawing conclusions about a population based on data from a sample of that population. In machine learning (ML), statistical inference is used to make predictions about new data based on data that has already been seen.5 The Wilcoxon rank-sum test, also known as the Mann-Whitney U test, is a non-parametric test that is used to compare the medians of two independent samples. It is a rank-based test, which means that it does not assume that the data is normally distributed. The Wilcoxon rank-sum test is calculated by first ranking the data from both samples, and then finding the sum of the ranks for one of the samples. The Wilcoxon rank-sum test statistic is then calculated by subtracting the sum of the ranks for one sample from the sum of the ranks for the other sample. The p-value for the Wilcoxon rank-sum test is calculated using a table of critical values. The p-value is the probability of obtaining a test statistic at least as extreme as the one observed, assuming that the null hypothesis is true.6,7
For further technical information as per how our model work we invite you to visit the article below:
TNGX Stock Forecast (Buy or Sell) Strategic Interaction Table
Strategic Interaction Table Legend:
X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)
Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)
Z axis (Grey to Black): *Technical Analysis%
Financial Data Adjustments for Statistical Inference (ML) based TNGX Stock Prediction Model
- When designating a risk component as a hedged item, the hedge accounting requirements apply to that risk component in the same way as they apply to other hedged items that are not risk components. For example, the qualifying criteria apply, including that the hedging relationship must meet the hedge effectiveness requirements, and any hedge ineffectiveness must be measured and recognised.
- There is a rebuttable presumption that unless inflation risk is contractually specified, it is not separately identifiable and reliably measurable and hence cannot be designated as a risk component of a financial instrument. However, in limited cases, it is possible to identify a risk component for inflation risk that is separately identifiable and reliably measurable because of the particular circumstances of the inflation environment and the relevant debt market
- If, at the date of initial application, it is impracticable (as defined in IAS 8) for an entity to assess a modified time value of money element in accordance with paragraphs B4.1.9B–B4.1.9D on the basis of the facts and circumstances that existed at the initial recognition of the financial asset, an entity shall assess the contractual cash flow characteristics of that financial asset on the basis of the facts and circumstances that existed at the initial recognition of the financial asset without taking into account the requirements related to the modification of the time value of money element in paragraphs B4.1.9B–B4.1.9D. (See also paragraph 42R of IFRS 7.)
- If an entity has applied paragraph 7.2.6 then at the date of initial application the entity shall recognise any difference between the fair value of the entire hybrid contract at the date of initial application and the sum of the fair values of the components of the hybrid contract at the date of initial application in the opening retained earnings (or other component of equity, as appropriate) of the reporting period that includes the date of initial application.
*International Financial Reporting Standards (IFRS) adjustment process involves reviewing the company's financial statements and identifying any differences between the company's current accounting practices and the requirements of the IFRS. If there are any such differences, neural network makes adjustments to financial statements to bring them into compliance with the IFRS.
TNGX Tango Therapeutics Inc. Financial Analysis*
Rating | Short-Term | Long-Term Senior |
---|---|---|
Outlook* | B3 | B2 |
Income Statement | C | Caa2 |
Balance Sheet | Caa2 | Caa2 |
Leverage Ratios | B1 | Caa2 |
Cash Flow | Baa2 | B2 |
Rates of Return and Profitability | Caa2 | Caa2 |
*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?
References
- Jorgenson, D.W., Weitzman, M.L., ZXhang, Y.X., Haxo, Y.M. and Mat, Y.X., 2023. Tesla Stock: Hold for Now, But Watch for Opportunities. AC Investment Research Journal, 220(44).
- Athey S. 2017. Beyond prediction: using big data for policy problems. Science 355:483–85
- Jacobs B, Donkers B, Fok D. 2014. Product Recommendations Based on Latent Purchase Motivations. Rotterdam, Neth.: ERIM
- Efron B, Hastie T. 2016. Computer Age Statistical Inference, Vol. 5. Cambridge, UK: Cambridge Univ. Press
- Cortes C, Vapnik V. 1995. Support-vector networks. Mach. Learn. 20:273–97
- V. Mnih, K. Kavukcuoglu, D. Silver, A. Rusu, J. Veness, M. Bellemare, A. Graves, M. Riedmiller, A. Fidjeland, G. Ostrovski, S. Petersen, C. Beattie, A. Sadik, I. Antonoglou, H. King, D. Kumaran, D. Wierstra, S. Legg, and D. Hassabis. Human-level control through deep reinforcement learning. Nature, 518(7540):529–533, 02 2015.
- T. Shardlow and A. Stuart. A perturbation theory for ergodic Markov chains and application to numerical approximations. SIAM journal on numerical analysis, 37(4):1120–1137, 2000
Frequently Asked Questions
Q: Is TNGX stock expected to rise?A: TNGX stock prediction model is evaluated with Statistical Inference (ML) and Wilcoxon Rank-Sum Test and it is concluded that dominant strategy for TNGX stock is Sell
Q: Is TNGX stock a buy or sell?
A: The dominant strategy among neural network is to Sell TNGX Stock.
Q: Is Tango Therapeutics Inc. stock a good investment?
A: The consensus rating for Tango Therapeutics Inc. is Sell and is assigned short-term B3 & long-term B2 estimated rating.
Q: What is the consensus rating of TNGX stock?
A: The consensus rating for TNGX is Sell.
Q: What is the forecast for TNGX stock?
A: TNGX target price forecast: Sell